Copyright Reports & Markets. All rights reserved.

Global Phenylketonuria (PKU) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Phenylketonuria (PKU) Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Medications
    • 1.3.3 Supplements
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Phenylketonuria (PKU) Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Household
    • 1.4.3 Hospital
  • 1.5 Global Phenylketonuria (PKU) Market Size & Forecast
    • 1.5.1 Global Phenylketonuria (PKU) Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Phenylketonuria (PKU) Sales Quantity (2020-2031)
    • 1.5.3 Global Phenylketonuria (PKU) Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Biomarin
    • 2.1.1 Biomarin Details
    • 2.1.2 Biomarin Major Business
    • 2.1.3 Biomarin Phenylketonuria (PKU) Product and Services
    • 2.1.4 Biomarin Phenylketonuria (PKU) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Biomarin Recent Developments/Updates
  • 2.2 Mead Johnson
    • 2.2.1 Mead Johnson Details
    • 2.2.2 Mead Johnson Major Business
    • 2.2.3 Mead Johnson Phenylketonuria (PKU) Product and Services
    • 2.2.4 Mead Johnson Phenylketonuria (PKU) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Mead Johnson Recent Developments/Updates
  • 2.3 Abbott
    • 2.3.1 Abbott Details
    • 2.3.2 Abbott Major Business
    • 2.3.3 Abbott Phenylketonuria (PKU) Product and Services
    • 2.3.4 Abbott Phenylketonuria (PKU) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Abbott Recent Developments/Updates
  • 2.4 Nutricia
    • 2.4.1 Nutricia Details
    • 2.4.2 Nutricia Major Business
    • 2.4.3 Nutricia Phenylketonuria (PKU) Product and Services
    • 2.4.4 Nutricia Phenylketonuria (PKU) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Nutricia Recent Developments/Updates
  • 2.5 Dr. Schär
    • 2.5.1 Dr. Schär Details
    • 2.5.2 Dr. Schär Major Business
    • 2.5.3 Dr. Schär Phenylketonuria (PKU) Product and Services
    • 2.5.4 Dr. Schär Phenylketonuria (PKU) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Dr. Schär Recent Developments/Updates
  • 2.6 Vitaflo
    • 2.6.1 Vitaflo Details
    • 2.6.2 Vitaflo Major Business
    • 2.6.3 Vitaflo Phenylketonuria (PKU) Product and Services
    • 2.6.4 Vitaflo Phenylketonuria (PKU) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Vitaflo Recent Developments/Updates
  • 2.7 Cambrooke
    • 2.7.1 Cambrooke Details
    • 2.7.2 Cambrooke Major Business
    • 2.7.3 Cambrooke Phenylketonuria (PKU) Product and Services
    • 2.7.4 Cambrooke Phenylketonuria (PKU) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Cambrooke Recent Developments/Updates
  • 2.8 PKU Perspectives
    • 2.8.1 PKU Perspectives Details
    • 2.8.2 PKU Perspectives Major Business
    • 2.8.3 PKU Perspectives Phenylketonuria (PKU) Product and Services
    • 2.8.4 PKU Perspectives Phenylketonuria (PKU) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 PKU Perspectives Recent Developments/Updates
  • 2.9 Firstplay Dietary
    • 2.9.1 Firstplay Dietary Details
    • 2.9.2 Firstplay Dietary Major Business
    • 2.9.3 Firstplay Dietary Phenylketonuria (PKU) Product and Services
    • 2.9.4 Firstplay Dietary Phenylketonuria (PKU) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Firstplay Dietary Recent Developments/Updates

3 Competitive Environment: Phenylketonuria (PKU) by Manufacturer

  • 3.1 Global Phenylketonuria (PKU) Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Phenylketonuria (PKU) Revenue by Manufacturer (2020-2025)
  • 3.3 Global Phenylketonuria (PKU) Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Phenylketonuria (PKU) by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Phenylketonuria (PKU) Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Phenylketonuria (PKU) Manufacturer Market Share in 2024
  • 3.5 Phenylketonuria (PKU) Market: Overall Company Footprint Analysis
    • 3.5.1 Phenylketonuria (PKU) Market: Region Footprint
    • 3.5.2 Phenylketonuria (PKU) Market: Company Product Type Footprint
    • 3.5.3 Phenylketonuria (PKU) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Phenylketonuria (PKU) Market Size by Region
    • 4.1.1 Global Phenylketonuria (PKU) Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Phenylketonuria (PKU) Consumption Value by Region (2020-2031)
    • 4.1.3 Global Phenylketonuria (PKU) Average Price by Region (2020-2031)
  • 4.2 North America Phenylketonuria (PKU) Consumption Value (2020-2031)
  • 4.3 Europe Phenylketonuria (PKU) Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Phenylketonuria (PKU) Consumption Value (2020-2031)
  • 4.5 South America Phenylketonuria (PKU) Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Phenylketonuria (PKU) Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Phenylketonuria (PKU) Sales Quantity by Type (2020-2031)
  • 5.2 Global Phenylketonuria (PKU) Consumption Value by Type (2020-2031)
  • 5.3 Global Phenylketonuria (PKU) Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Phenylketonuria (PKU) Sales Quantity by Application (2020-2031)
  • 6.2 Global Phenylketonuria (PKU) Consumption Value by Application (2020-2031)
  • 6.3 Global Phenylketonuria (PKU) Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Phenylketonuria (PKU) Sales Quantity by Type (2020-2031)
  • 7.2 North America Phenylketonuria (PKU) Sales Quantity by Application (2020-2031)
  • 7.3 North America Phenylketonuria (PKU) Market Size by Country
    • 7.3.1 North America Phenylketonuria (PKU) Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Phenylketonuria (PKU) Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Phenylketonuria (PKU) Sales Quantity by Type (2020-2031)
  • 8.2 Europe Phenylketonuria (PKU) Sales Quantity by Application (2020-2031)
  • 8.3 Europe Phenylketonuria (PKU) Market Size by Country
    • 8.3.1 Europe Phenylketonuria (PKU) Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Phenylketonuria (PKU) Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Phenylketonuria (PKU) Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Phenylketonuria (PKU) Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Phenylketonuria (PKU) Market Size by Region
    • 9.3.1 Asia-Pacific Phenylketonuria (PKU) Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Phenylketonuria (PKU) Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Phenylketonuria (PKU) Sales Quantity by Type (2020-2031)
  • 10.2 South America Phenylketonuria (PKU) Sales Quantity by Application (2020-2031)
  • 10.3 South America Phenylketonuria (PKU) Market Size by Country
    • 10.3.1 South America Phenylketonuria (PKU) Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Phenylketonuria (PKU) Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Phenylketonuria (PKU) Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Phenylketonuria (PKU) Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Phenylketonuria (PKU) Market Size by Country
    • 11.3.1 Middle East & Africa Phenylketonuria (PKU) Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Phenylketonuria (PKU) Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Phenylketonuria (PKU) Market Drivers
  • 12.2 Phenylketonuria (PKU) Market Restraints
  • 12.3 Phenylketonuria (PKU) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Phenylketonuria (PKU) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Phenylketonuria (PKU)
  • 13.3 Phenylketonuria (PKU) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Phenylketonuria (PKU) Typical Distributors
  • 14.3 Phenylketonuria (PKU) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Phenylketonuria (PKU) market size was valued at US$ 1664 million in 2024 and is forecast to a readjusted size of USD 3212 million by 2031 with a CAGR of 10.0% during review period.
    This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
    This report mainly focuses on the treatment for PKU.
    In the global Phenylketonuria (PKU) market, the main companies are Biomarin, Mead Johnson, Dr. Schär and Abbott, with a market share of more than 50%. The main regions are North America and Europe, with a market share of more than 70%. Supplements have the largest share of the Phenylketonuria (PKU) market, exceeding 50%. The application scenarios of Phenylketonuria (PKU) are mainly concentrated on Household, with a market share of approximately 70%.
    This report is a detailed and comprehensive analysis for global Phenylketonuria (PKU) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Phenylketonuria (PKU) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
    Global Phenylketonuria (PKU) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
    Global Phenylketonuria (PKU) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
    Global Phenylketonuria (PKU) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Phenylketonuria (PKU)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Phenylketonuria (PKU) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biomarin, Mead Johnson, Abbott, Nutricia, Dr. Schär, Vitaflo, Cambrooke, PKU Perspectives, Firstplay Dietary, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Phenylketonuria (PKU) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Medications
    Supplements
    Others
    Market segment by Application
    Household
    Hospital
    Major players covered
    Biomarin
    Mead Johnson
    Abbott
    Nutricia
    Dr. Schär
    Vitaflo
    Cambrooke
    PKU Perspectives
    Firstplay Dietary
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Phenylketonuria (PKU) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Phenylketonuria (PKU), with price, sales quantity, revenue, and global market share of Phenylketonuria (PKU) from 2020 to 2025.
    Chapter 3, the Phenylketonuria (PKU) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Phenylketonuria (PKU) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Phenylketonuria (PKU) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Phenylketonuria (PKU).
    Chapter 14 and 15, to describe Phenylketonuria (PKU) sales channel, distributors, customers, research findings and conclusion.

    Buy now